Streetbeat News

Products Services

AVGR

Avinger has announced the full commercial launch of its Pantheris LV Image-Guided Atherectomy Device, which is expected to enhance their product offerings in the medical device market.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:36 pm

AAPL

Apple Inc. is reportedly set to launch its iPhone 16 series on September 10, 2024, according to a leaked invite. The event is expected to introduce a new Desert Titanium color and a charging boost, but may skip AI integration. The authenticity of the invite remains uncertain.

Portfolio Pulse from Rounak Jain

August 20, 2024 | 12:35 pm

AXP

EQT

TSLA

On CNBC's 'Halftime Report Final Trades,' American Express, Tesla, and EQT Corporation were highlighted. American Express reported mixed Q2 results but raised its EPS outlook. Tesla's CEO discussed future humanoid robots in warfare. EQT posted better-than-expected Q2 results.

Portfolio Pulse from Avi Kapoor

August 20, 2024 | 12:33 pm

AISP

Airship AI has been awarded a contract by the Department of Defense for its Acropolis Enterprise Video and Data Management Platform. The contract includes a base year and four option years.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:33 pm

AIM

AIM ImmunoTech Inc. announced the print publication of data from an Early Access Program studying Ampligen for advanced pancreatic cancer, published in Clinical Cancer Research.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:32 pm

AMPG

AmpliTech Group's AGTGSS division has signed a Memorandum of Understanding (MoU) for the initial deployment of a domestic private 5G network. This development could enhance AmpliTech's position in the 5G market.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:31 pm

PRFX

PainReform has announced early safety results from its Phase 3 bunionectomy study of PRF-110, showing a low incidence of adverse events, averaging just one per subject.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:31 pm

EVFM

Evofem Biosciences is highlighting the potential impact of GLP-1 medications on oral contraceptive effectiveness and promoting Phexxi as a non-oral contraceptive solution.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:19 pm

LUCD

PAVM

Lucid Diagnostics Inc. has published a study validating its EsoGuard test for early detection of esophageal precancer and cancer. The study is available in the journal Diagnostics.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 12:18 pm

LLY

Eli Lilly's tirzepatide shows promising results in reducing diabetes risk and achieving sustained weight loss over three years, according to the SURMOUNT-1 study. The drug, sold as Zepbound and Mounjaro, demonstrated significant efficacy in adults with pre-diabetes and obesity.

Portfolio Pulse from Vandana Singh

August 20, 2024 | 12:17 pm